Home
Christopher M. Jewell, Chief Scientific Officer: Cartesian Therapeutics RNAC Sell · Filed 24/11/18
Trade details
- Type
- Insider sale
- Amount
- $303,107
- Shares · price
- 18,550 sh · $16.34 a share
- Held after
- 43,440 sh
- Trade date
- 24/11/14
- Filed
- 24/11/18
- Days to filing
- 4 days
Sold 29.9% of holdings
- Share of holding sold
- 29.9%
Cartesian Therapeutics trades, last 26 weeks
What else happened in Cartesian Therapeutics around then
Filed or reported within 30 days of the trade day · 24/10/15~24/12/14Christopher M. Jewell's recent trades
- Christopher M. Jewell
Planned saleCartesian Therapeutics
Planned saleCartesian Therapeutics
RNAC
$68.9K
9,000 sh
$68.9K
Filed 01/13
Traded 01/13
- Christopher M. Jewell
Planned saleCartesian Therapeutics
Planned saleCartesian Therapeutics
RNAC
$12.1K
1,510 sh
$12.1K
Filed 01/09
Traded 01/09
- Christopher M. Jewell
Planned saleCartesian Therapeutics
Planned saleCartesian Therapeutics
RNAC
$192.6K
26,935 sh
$192.6K
Filed 25/11/19
Traded 25/11/19
- Christopher M. Jewell
SellCartesian Therapeutics
SellCartesian Therapeutics
RNAC
$21.6K
1,286 sh
$21.6K
Filed 25/01/07
Traded 25/01/06
- Christopher M. Jewell
SellCartesian Therapeutics
SellCartesian Therapeutics
RNAC
$21.1K
1,264 sh
$21.1K
Filed 25/01/07
Traded 25/01/03